ANTIGENICS INC. SECURITIES EXCHANGE AGREEMENTSecurities Exchange Agreement • March 16th, 2011 • Agenus Inc • Biological products, (no disgnostic substances) • New York
This Securities Exchange Agreement (this “Agreement”) is made as of December 28, 2010 by and between ANTIGENICS INC., a Delaware corporation (the “Company”), and INGALLS & SNYDER VALUE PARTNERS L.P. (the “Bond Holder”),
AMENDMENT – NUMBER TWO TO EMPLOYMENT AGREEMENT December 15, 2010Employment Agreement • March 16th, 2011 • Agenus Inc • Biological products, (no disgnostic substances)
This Amendment Number Two to the Employment Agreement (the “Employment Agreement”) by and between Antigenics Inc. (the “Company”) and Kerry Wentworth (the “Executive”) effective as of the 20th day of February, 2007, as amended by Amendment Number One, effective as of July 2, 2009, amends the Employment Agreement effective as of the date hereof as follows:
ANTIGENICS INC. SECURITIES REPURCHASE AGREEMENTSecurities Repurchase Agreement • March 16th, 2011 • Agenus Inc • Biological products, (no disgnostic substances) • New York
This Securities Repurchase Agreement (this “Agreement”) is made as of December 7, 2010 (the “Effective Date”) by and between ANTIGENICS INC., a Delaware corporation (the “Company”), and INGALLS & SNYDER VALUE PARTNERS L.P. (the “Bond Holder”).
SECOND AMENDMENT TO EMPLOYMENT AGREEMENT December 15, 2010Employment Agreement • March 16th, 2011 • Agenus Inc • Biological products, (no disgnostic substances)
This Second Amendment to the Employment Agreement by and between Antigenics Inc. (the “Company”) and Garo Armen (the “Executive”) effective as of the 1st day of December, 2005, as amended by the First Amendment effective as of the 2nd day of July, 2009 (the “Employment Agreement”) amends the Employment Agreement effective as of the date hereof as follows:
